Overview
Koichi Shibata practices practicing medicine in Tokyo, Japan.
His clinical expertise encompasses Respiratory Alkalosis, Small Cell Lung Cancer (SCLC), and Hyperventilation.
He is actively involved in clinical research, co-authoring 26 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Koichi Shibata
Is Koichi Shibata a top-rated expert for Respiratory Alkalosis?
MediFind is an objective health platform that identifies experts based on real-world data. Koichi Shibata is classified as an Experienced expert for Respiratory Alkalosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Koichi Shibata participate in research or clinical trials?
Yes. Koichi Shibata has published 26 articles and abstracts on conditions like Respiratory Alkalosis. You can view a list of Koichi Shibata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HyperventilationMr. Shibata isExperienced. Learn about Hyperventilation.
- Respiratory AlkalosisMr. Shibata isExperienced. Learn about Respiratory Alkalosis.
- Small Cell Lung Cancer (SCLC)Mr. Shibata isExperienced. Learn about Small Cell Lung Cancer (SCLC).